Tenders of Dak Gesundheit

Tenders of Dak Gesundheit

DAK Gesundheit Tender

Germany
Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient paliperidone (exclusively 3-month depot), Atc N05ax13 for the period January 1st, 2024 - December 31st, 2025
Closing Date5 Dec 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Maraviroc, Atc J05ax09 Für Die Zeit 01.01.2024 - 31.12.2025
Closing Date5 Dec 2025
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Others
Germany
Completion of a non-exclusive discount agreement According to § 130a para. 8 Sgb W To the active ingredient Tezepelumab, Atc R03dx11 For The Time 01.06.2023 - 31.05.2025
Closing Date5 Apr 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Germany
Germany-hamburg: Pharmaceutical Products
Closing Date5 Aug 2025
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient triptorelin, ATC L02ae04 (obo) for the period 01.09.2024 - 31.08.2026
Closing Date5 Jul 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Germany
Germany-hamburg: Pharmaceutical Products
Closing Date5 Dec 2024
Tender AmountRefer Documents 

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Germany-hamburg: Pharmaceutical Products
Closing Date5 May 2025
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Others
Germany
Completion of a non-exclusive discount agreement According to § 130a para. 8 Sgb W To the active ingredient Pimecrolimus, Atc D11ah02 For The Time 01.05.2023 - 30.04.2025 (1003891- Pimecrolimus, Atc D11ah02)
Closing Date5 Mar 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Germany
Germany-hamburg: Pharmaceutical Products
Closing Date5 Jun 2025
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 Sgb V for the active ingredient Tocilizumab, Atc L04ac07 for the period December 1st, 2023 - November 30th, 2024 (plus extension option 1x12 months) (1004084 - Tocilizumab (exclusively pre-filled syringe and
Closing Date5 Oct 2025
Tender AmountRefer Documents 
51-60 of 342 active Tenders